By Business/Source
Currency:EUR
2025/Q2
2025/Q2
2024/FY
2024/Q2
2023/FY
2023/Q4
2023/Q3
2023/Q2
2022/FY
2022/Q4
2022/Q3
2022/Q2
2021/FY
2021/Q2
2020/FY
2020/Q2
2019/FY
2018/FY
2017/FY
2016/FY
2015/FY
2015/Q4
2015/Q3
2014/FY
2014/Q4
2014/Q3
2014/Q2
2014/Q1
2013/FY
2013/Q4
2013/Q3
2013/Q1
2012/FY
2012/Q4
2012/Q3
2012/Q2
2008/FY
2007/FY
2006/FY
Stock NameRevenueRatio
BioPharma1.63B86.33%
Diagnostic161.59M8.54%
Others60.51M3.20%
Bio Supplies36.4M1.92%
By Country/Region
Currency:EUR
2024/FY
2024/FY
2023/FY
2022/FY
2021/FY
2020/FY
2019/FY
2018/FY
2017/FY
2016/FY
2015/FY
2015/Q4
2015/Q3
2015/Q1
2014/FY
2014/Q4
2014/Q3
2014/Q2
2014/Q1
2013/FY
2013/Q4
2013/Q3
2012/FY
2012/Q2
2008/FY
2007/FY
2006/FY
Stock NameRevenueRatio
USA and Canada4.09B56.67%
Rest of the World1.58B21.96%
European Union1.12B15.50%
Spain423.08M5.87%